Sugar water injection may ease carpal tunnel pain
NCT ID NCT07524933
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting a 5% dextrose (sugar water) solution around the nerve in the wrist can reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome. About 96 adults who haven't gotten better with standard care will receive the injection under ultrasound guidance. Researchers will measure pain, hand function, nerve size, and electrical activity to see if this simple treatment works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 5% dextrose (sugar water) injection
- What this could lead to
- If it works, this could offer a non-surgical option to reduce pain and improve hand function for people with carpal tunnel syndrome.
- What could go wrong
- This is a small, early-stage trial with no phase, so results may not be conclusive. The injection is compared to a placebo, so any benefit might be due to the procedure itself rather than the sugar water.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
96 people
The number who actually took part.
- Started
-
Jan 2026
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-80 years * Clinical and electrophysiological diagnosis of mild to moderate carpal tunnel syndrome * Symptom duration of at least 3 months * Both male and female participants * Patients who have not responded adequately to conservative treatment * Patients who do not wish to undergo surgical treatment * Ability to provide informed consent Exclusion Criteria: * Severe or very severe carpal tunnel syndrome based on EMG findings * Previous injection therapy for carpal tunnel syndrome * Prior wrist or carpal tunnel surgery * Polyneuropathy or other peripheral neuropathies * Cervical radiculopathy or proximal median nerve entrapment * Brachial plexopathy or thoracic outlet syndrome * Pregnancy * Malignancy * Local or systemic infection * Cognitive impairment affecting cooperation * Systemic diseases affecting the median nerve (e.g., uncontrolled diabetes mellitus, thyroid disorders)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antalya Eğitim Araştırma Hastanesi
Antalya, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does mixing numbing agent into steroid shots ease hand pain?
- Blood protein may reveal how severe carpal tunnel syndrome is
- A carpal tunnel clue to a silent heart threat?
- Taping technique may offer Drug-Free relief for wrist pain
- One size Doesn't fit all: could pain 'Phenotypes' unlock better carpal tunnel care?
- Ultrasound may reveal hidden clues in carpal tunnel syndrome